Differential regulation of D-type cyclins in the mouse intestine

Cell Cycle

Volumn 5, Issue 2, 2006, Pages 180-183

  Yang, Ruyan ^a   Bie, Wenjun ^a   Haegebarth, Andrea ^a   Tyner, Angela L ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

D1; D2; D3; DSS; IMCE; YAMC

Indexed keywords

CYCLIN D; CYCLIN D1; CYCLIN D2; CYCLIN D3; MESSENGER RNA; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL IMMORTALIZATION; CELL PROLIFERATION; COLITIS; COLON; COLON MUCOSA; CONTROLLED STUDY; DISEASE MODEL; DUODENUM; EPITHELIUM CELL; ILEUM; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INTESTINE; LARGE INTESTINE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; RNA ANALYSIS; SMALL INTESTINE; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 31144457342     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.5.2.2306     Document Type: Article

References (33)

1. Sherr CJ. Mammalian G1 cyclins. Cell 1993; 73:1059-65.
2. Morgan DO. Principles of CDK regulation. Nature 1995; 374:131-4.
3. 1 cyclin-dependent kinases in the mammalian cell cycle. Curr Opin Cell Biol 2000; 12:676-84.
4. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999; 13:1501-12.
5. Mittnacht S. Control of pRB phosphorylation. Curr Opin Genet Dev 1998; 8:21-7.
6. Kaelin WG, Jr. Functions of the retinoblastoma protein. Bioessays 1999; 21:950-8.
7. Gordon JI, Schmidt GH, Roth KA. Studies of intestinal stem cells using normal, chimeric and transgenic mice. FASEB J 1992; 6:3039-50.
8. Potten CS, Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls, and uncertainties. Lessons for and from the crypt. Development 1990; 110:1001-20.
9. Matsushime H, Roussel MF, Sherr CJ. Novel mammalian cyclins (CYL genes) expressed during G1. Cold Spring Harb Symp Quant Biol 1991; 56:69-74.
10. Moser AR, Luongo C, Gould KA, McNeley MK, Shoemaker AR, Dove WF. ApcMin: a mouse model for intestinal and mammary tumorigenesis. Eur J Cancer 1995; 31A:1061-4.
11. Whitehead RH, VanEeden PE, Noble MD, Ataliotis P, Jat PS. Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice. Proc Natl Acad Sci U S A 1993; 90:587-91.
12. D'Abaco GM, Whitehead RH, Burgess AW. Synergy between Apc min and an activated ras mutation is sufficient to induce coton carcinomas. Mol Cell Biol 1996; 16:884-91.
13. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 1994; 8:9-22.
14. Yanagisawa K, Kosaka A, Iwahana H, Nakanishi M, Tominaga S. Opposite regulation of the expression of cyclin-dependent kinase inhibitors during contact inhibition. J Biochem (Tokyo) 1999; 125:36-40.
15. Sansom OJ, Reed KR, Hayes AJ, Ireland H, Brinkmann H, Newton IP, Batlle E, Simon-Assmann P, Clevers H, Nathke IS, Clarke AR, Winton DJ. Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev 2004; 18:1385-90.
16. Back SH, Kioussi C, Briata P, Wang D, Nguyen HD, Ohgi KA, Glass CK, Wynshaw-Boris A, Rose DW, Rosenfeld MG. Regulated subset of G1 growth-control genes in response to derepression by the Wnt pathway. Proc Natl Acad Sci USA 2003; 100:3245-50.
17. Sansom OJ, Reed KR, van de Wetering M, Muncan V, Winton DJ, Clevers H, Clarke AR. Cycfin D1 is not an immediate target of beta-catenin following Apc loss in the intestine. J Biol Chem 2005; 280:28463-7.
18. Hulit J, Wang C, Li Z, Albanese C, Rao M, Di Vizio D, Shah S, Byers SW, Mahmood R, Augenlicht LH, Russell R, Pestell RG. Cyclin D1 genetic heterozygosity regulates colonic epithelial cell differentiation and tumor number in ApcMin mice. Mol Cell Biol 2004; 24:7598-611.
19. Clevers H. At the crossroads of inflammation and cancer. Cell 2004; 118:671-4.
20. Tessner TG, Cohn SM, Schloemann S, Stenson WF. Prostaglandins prevent decreased epithelial cell proliferation associated with dextran sodium sulfate injury in mice. Gastroenterology 1998; 115:874-82.
21. Pagano M, Jackson PK. Wagging the dogma; tissue-specific cell cycle control in the mouse embryo. Cell 2004; 118:535-8.
22. Ciemerych MA, Sicinski P. Cell cycle in mouse development. Oncogene 2005; 24:2877-98.
23. Sherr CJ, Roberts JM. Living with or without cyclins and cyclin-dependent kinases. Genes Dev 2004; 18:2699-711.
24. Kozar K, Sicinski P. Cell cycle progression without cyclin D-CDK4 and cyclin D-CDK6 complexes. Cell Cycle 2005; 4:388-91.
25. Kozar K, Ciemerych MA, Rebel VI, Shigematsu H, Zagozdzon A, Sicinska E, Geng Y, Yu Q, Bhattacharya S, Bronson RT, Akashi K, Sicinski P. Mouse development and cell proliferation in the absence of D-cyclins. Cell 2004; 118:477-91.
26. Sicinski P, Donaher JL, Parker SB, Li T, Fazeli A, Gardner H, Haslam SZ, Bronson RT, Elledge SJ, Weinberg RA. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 1995; 82:621-30.
27. Deshpande A, Sicinski P, Hinds PW. Cyclins and cdks in development and cancer: a perspective. Oncogene 2005; 24:2909-15.
28. Arber N, Hibshoosh H, Moss SF, Sutter T, Zhang Y, Begg M, Wang S, Weinstein IB, Holt PR. Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology 1996; 110:669-74.
29. Sutter T, Doi S, Carnevale KA, Arber N, Weinstein IB. Expression of cyclins D1 and E in human colon adenocarcinomas. J Med 1997;28(5-6):285-309.
30. Bartkova J, Thullberg M, Slezak P, Jaramillo E, Rubio C, Thomassen LH, Bartek J. Aberrant expression of G1-phase cell cycle regulators in flat and exophytic adenomas of the human colon. Gastroenterology 2001; 120:1680-8.
31. Mermelshtein A, Gerson A, Walfisch S, Delgado B, Shechter-Maor G, Delgado J, Fich A, Gheber L. Expression of D-type cyclins in colon cancer and in cell lines from colon carcinomas. Br J Cancer 2005; 93:338-45.
32. Haigis KM, Hoff PD, White A, Shoemaker AR, Halberg RB, Dove WF. Tumor regionality in the mouse intestine reflects the mechanism of loss of Apc function. Proc Natl Acad Sci USA 2004; 101:9769-73.
33. Haegebarth A, Heap D, Bie W, Deny JJ, Richard S, Tyner AL. The nuclear tyrosine kinase BRK/Sik phosphorylates and inhibits the RNA-binding activities of the Sam68-like mammalian proteins SLM-1 and SLM-2. J Biol Chem 2004; 279:54398-404.